Pfizer Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Meenakshi Nevatia
Chief executive officer
₹94.8m
Total compensation
| CEO salary percentage | 55.30% |
| CEO tenure | 2.7yrs |
| CEO ownership | n/a |
| Management average tenure | 2.2yrs |
| Board average tenure | 2.4yrs |
Recent management updates
Recent updates
Pfizer's (NSE:PFIZER) Solid Profits Have Weak Fundamentals
Nov 25
Pinning Down Pfizer Limited's (NSE:PFIZER) P/E Is Difficult Right Now
Sep 13Subdued Growth No Barrier To Pfizer Limited (NSE:PFIZER) With Shares Advancing 28%
May 28Pfizer (NSE:PFIZER) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
May 26Pfizer Limited's (NSE:PFIZER) Share Price Not Quite Adding Up
Mar 03Some Confidence Is Lacking In Pfizer Limited's (NSE:PFIZER) P/E
Nov 28We Think Pfizer (NSE:PFIZER) Can Stay On Top Of Its Debt
Aug 31Subdued Growth No Barrier To Pfizer Limited (NSE:PFIZER) With Shares Advancing 25%
Aug 07Weak Statutory Earnings May Not Tell The Whole Story For Pfizer (NSE:PFIZER)
May 25Pfizer (NSE:PFIZER) Has A Pretty Healthy Balance Sheet
Feb 13Pfizer Limited's (NSE:PFIZER) Business Is Yet to Catch Up With Its Share Price
Jan 17Here's Why Pfizer (NSE:PFIZER) Can Manage Its Debt Responsibly
Mar 15A Look At The Intrinsic Value Of Pfizer Limited (NSE:PFIZER)
Jul 20Pfizer (NSE:PFIZER) Could Easily Take On More Debt
Mar 29Calculating The Fair Value Of Pfizer Limited (NSE:PFIZER)
Feb 07CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | ₹8b |
| Jun 30 2025 | n/a | n/a | ₹8b |
| Mar 31 2025 | ₹95m | ₹52m | ₹8b |
| Dec 31 2024 | n/a | n/a | ₹6b |
| Sep 30 2024 | n/a | n/a | ₹6b |
| Jun 30 2024 | n/a | n/a | ₹6b |
| Mar 31 2024 | ₹72m | ₹49m | ₹6b |
Compensation vs Market: Meenakshi's total compensation ($USD1.05M) is above average for companies of similar size in the Indian market ($USD673.68K).
Compensation vs Earnings: Meenakshi's compensation has increased by more than 20% in the past year.
CEO
Meenakshi Nevatia (55 yo)
Mrs. Meenakshi Nevatia serves as Non-Executive Independent Director at TeamLease Services Ltd. since July 28, 2021. Mrs. Nevatia is the Managing Director of Stryker India since October 2018.She has been M...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Director | 2.7yrs | ₹94.83m | no data | |
| Director of Corporate Services | 18.3yrs | ₹11.30m | no data | |
| Whole-Time Director & Executive Director of Plant Operations | 2.2yrs | ₹14.80m | no data | |
| Senior Director of Business Operations | no data | no data | no data | |
| Senior Director of Policy & Public Affairs | no data | no data | no data | |
| Strategic Partnerships | 1.1yrs | no data | no data | |
| India Digital Client Partner Lead & Director of Digital | 2.3yrs | no data | no data | |
| Category Lead of Internal Medicine | 1.1yrs | no data | no data |
Experienced Management: PFIZER's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Director | 2.7yrs | ₹94.83m | no data | |
| Whole-Time Director & Executive Director of Plant Operations | 2.2yrs | ₹14.80m | no data | |
| Independent Woman Director | 6.8yrs | ₹2.39m | no data | |
| Non-Executive Independent Director | 1.4yrs | ₹1.62m | 0.000020% ₹ 45.5k | |
| Non-Executive Non-Independent Chairman | 26yrs | ₹2.46m | no data | |
| Independent Director | 1.4yrs | ₹1.55m | no data |
Experienced Board: PFIZER's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/03 01:05 |
| End of Day Share Price | 2025/12/03 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Pfizer Limited is covered by 10 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sriraam Rathi | Anand Rathi Shares and Stock Brokers Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Rohit Bhat | Batlivala & Karani Securities India Pvt. Ltd. |